Published On: April 25, 2023Categories: Podcast

We are proud to present the 6th episode of our successful All Things Urticaria Podcst Series

In this episode, Professors Marcus Maurer and Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma & Immunology (AAAAI) conference held in San Antonio, Texas. In particular, Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussion by outlining ongoing projects and upcoming projects within UCARE that will be presented at the forthcoming UCARE conference in São Paulo in 2023.

Do you have suggestions for future episodes? Please reach out to us via  email or fill out this form here and offer your suggestions for future topics and expert selection!

Read more news regarding urticaria

  • News

    April 15, 2024

    With 85 episodes, our podcast all Things Urticaria has reached 30.000 downloads! Listen to all episodes here: SPOTIFY APPLE PODCAST

  • New centers,News

    April 12, 2024

    On March 28, Marcus Mauer had the great privilege to perform a triple re-audit for  UCARE, ACARE and ADCARE  at the Peking University First Hospital Center in Beijing, China. [...]

  • New centers,News

    April 12, 2024

    A very warm welcome to our newest UCARE (and ACARE) Center in Spain: Hospital General Universitario Gregorio Marañón Allergy Department Head: Dr. Ana Entrala Bueso Deputy: Dr. María Luisa Baeza [...]